The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Update

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) saw a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 23,400 shares, an increase of 963.6% from the August 15th total of 2,200 shares. Based on an average daily trading volume, of 18,700 shares, the days-to-cover ratio is presently 1.3 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Performance

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 stock traded down $0.05 during trading hours on Thursday, reaching $19.41. 23,246 shares of the company’s stock were exchanged, compared to its average volume of 20,687. The firm’s 50 day simple moving average is $18.96 and its 200 day simple moving average is $18.84. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a twelve month low of $15.73 and a twelve month high of $20.75.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Thursday, August 1st were paid a dividend of $0.2891 per share. The ex-dividend date was Thursday, August 1st. This represents a $1.16 annualized dividend and a yield of 5.96%.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Company Profile

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.